A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy
2013 · Brachytherapy · 129 citations
https://doi.org/10.1016/j.brachy.2013.11.005
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Chu Cheng Kan is an academic researcher.
Click to start Chat